simvastatin has been researched along with Brain Ischemia in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.00) | 18.2507 |
2000's | 24 (48.00) | 29.6817 |
2010's | 23 (46.00) | 24.3611 |
2020's | 2 (4.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Hu, Y; Qin, X; Wang, M; Wang, S; Wu, J; Wu, T; Wu, Y; Yang, R; Yu, H | 1 |
Isaka, Y; Nakamura, T; Nakayama, S; Taguchi, N; Tanaka, M | 1 |
Alahmari, A; Almalki, ZS; Alotaibi, N; Guo, JJ; Thaibah, H | 1 |
Liu, H; Xu, X | 1 |
Campos-Martorell, M; Hernandez-Guillamón, M; Montaner, J; Simats, A; Solé, M; Sun, P; Unzeta, M | 1 |
de Leeuw, FE; Koopman, A; Meijer, F | 1 |
Chen, Z; Liu, L; Liu, Z; Zhang, Z; Zhao, B | 1 |
Anderson, DC; Boden, WE; Chaitman, BR; Cruz-Flores, S; Goldstein, LB; Grant, S; Kostuk, WJ; Padley, RJ; Sila, CA; Teo, KK; Weintraub, WS | 1 |
Barlinn, K; Bodechtel, U; Gahn, G; Gehrisch, S; Grählert, X; Heinke, D; Kepplinger, J; Puetz, V; Reichmann, H; Schwanebeck, U; Siepmann, T | 1 |
Kirkpatrick, PJ; Turner, CL | 1 |
Britz, GW; Lombard, F; Warner, DS | 1 |
Corbett, AM; Flannery, T; Lizzi, J; Sanghvi, S; Sibbit, B; Sieber, S; Wyatt, N | 1 |
Guo, J; He, L; Li, J; Qin, F; Wu, B; Zhang, S; Zhou, D; Zhou, M | 1 |
Bradamante, V; Kelava, M; Konjevoda, P; Lovrić, J; Macan, M; Štambuk, N; Vrkić, N; Vukšić, A; Žunec, S | 1 |
Chicoine, M; Derdeyn, CP; Dhar, R; Diringer, MN; Powers, WJ; Scalfani, M; Zazulia, AR | 1 |
Campos-Martorell, M; Cano-Sarabia, M; Hernández-Guillamon, M; Maspoch, D; Montaner, J; Rosell, A; Simats, A | 1 |
Bravo, Y; Bustamante, A; Cánovas, D; Corbeto, N; de Arce, A; de la Torre, J; Delgado, P; Delgado-Mederos, R; Freijo, M; García-Matas, S; Giralt, D; Jiménez, C; Lago, A; Martínez-Zabaleta, M; Masjuán, J; Moniche, F; Montaner, J; Ribó, M; Rubio, FR; Segura, T; Tejada, J; Vives-Pastor, B | 1 |
Chen, J; Chopp, M; Cui, X; Zacharek, A | 1 |
Beyer, C; Heid, F; Kerz, T; Reisch, R; Trapp, I; Victor, A | 1 |
Shabanzadeh, AP; Shuaib, A; Wang, CX | 2 |
Czosnyka, M; Hutchinson, PJ; Kirkpatrick, PJ; Pickard, JD; Richards, HK; Tseng, MY; Turner, CL | 1 |
Coert, BA; Geskus, RB; Horn, J; Meijers, JC; Roos, YB; Stroes, ES; van der Poll, T; Vergouwen, MD; Vermeulen, M | 1 |
de Haan, RJ; Kruyt, ND; Roos, YB; van Geloven, N; Vergouwen, MD; Vermeulen, M | 1 |
Chen, J; Chopp, M; Cui, X; Lu, M; Roberts, C; Shehadah, A | 1 |
Boaz, M; Gilad, R; Lampl, Y; Lorberboym, M; Sadeh, M; Tikozky, A; Vysberg, I | 1 |
Guluma, KZ; Lapchak, PA | 1 |
Beretta, S; Cattalini, A; de Curtis, M; Ferrarese, C; Librizzi, L; Pastori, C; Piazza, F; Sala, G | 1 |
Anderson, T; Boden, WE; Chaitman, BR; Desvignes-Nickens, P; Koprowicz, K; McBride, R; Probstfield, JL; Teo, K; Weintraub, W | 1 |
Du, D; Liu, M; Shen, L; Wang, J; Xia, C; Zhu, D; Zhu, M | 1 |
Chan, KY; Lee, MW; Liang, M; Po, YC; Poon, WS; Tan, H; Wong, GK | 1 |
Asdente, M; Balduini, W; Calvio, AM; Cimino, M; Guerrini, U; Lodetti, B; Paoletti, R; Sironi, L; Tremoli, E | 1 |
Audebert, H; Haberl, RL | 1 |
Armitage, J; Collins, R; Parish, S; Peto, R; Sleight, P | 1 |
Coull, BM | 1 |
Amin-Hanjani, S; Asahi, M; Huang, PL; Huang, Z; Liao, JK; Lo, EH; Mori, T; Moskowitz, MA; Qiu, J; Sumii, T; Thomas, S; Yoshimura, S | 1 |
Balduini, W; Carloni, S; Cimino, M; Gelosa, P; Guerrini, U; Sironi, L; Tremoli, E | 1 |
Alexander, MJ; Blessing, R; Coon, AL; Floyd, J; Friedman, AH; Graffagnino, C; Laskowitz, DT; Lynch, JR; McGirt, MJ; Wang, H; Warner, DS | 1 |
Ovbiagele, B | 1 |
Banfi, C; Brioschi, M; Cimino, M; Gelosa, P; Gianella, A; Guerrini, U; Nobili, E; Paoletti, R; Sironi, L; Tremoli, E | 1 |
Carod-Artal, FJ | 1 |
Gao, F; Song, T; Wu, JM; Zhang, J; Zhou, FY | 1 |
Cakmak, A; Dalkara, T; Dinçer, D; Köksoy, C; Yazgan, U; Yemişçi, M | 1 |
Kanorskiĭ, SG; Shevelev, VI; Zafiraki, VK; Zingilevskiĭ, KB | 1 |
Guyton, JR; Laskowitz, DT; Lynch, JR; Mace, B; Song, P; Wang, H; Warner, DS; Yang, HJ; Yates, RB | 1 |
Bassi, A; Caltagirone, C; Colivicchi, F; Santini, M | 1 |
Alvarez-Sabín, J; Chacón, P; Hereu, P; Krupinski, J; Millán, M; Molina, CA; Montaner, J; Quintana, M; Rubio, F | 1 |
Bleck, TP; Dumont, AS; Gurka, MJ; Kassell, NF; Kramer, AH; Nathan, B | 1 |
Thomas, U | 1 |
5 review(s) available for simvastatin and Brain Ischemia
Article | Year |
---|---|
Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
Topics: Anticholesteremic Agents; Brain Ischemia; Humans; Intracranial Aneurysm; Randomized Controlled Trials as Topic; Simvastatin; Subarachnoid Hemorrhage; Treatment Outcome | 2017 |
Cholesterol-reducing agents for aneurysmal subarachnoid haemorrhage.
Topics: Anticholesteremic Agents; Brain Ischemia; Humans; Incidence; Randomized Controlled Trials as Topic; Simvastatin; Subarachnoid Hemorrhage; Treatment Outcome | 2013 |
[Secondary prevention after stroke: healthy life style, oral anticoagulation].
Topics: Administration, Oral; Adult; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Blood Coagulation Disorders; Brain Ischemia; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarction; Clinical Trials as Topic; Contraceptives, Oral; Embolism; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Ischemic Attack, Transient; Life Style; Male; Phenprocoumon; Platelet Aggregation Inhibitors; Recurrence; Simvastatin; Smoking Cessation; Stroke | 2003 |
Statin therapy after acute ischemic stroke in the heart protection study: is the role in recurrent stroke prevention now defined?
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Coronary Disease; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Risk; Risk Factors; Simvastatin; Vitamins | 2004 |
Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia.
Topics: Aging; Animals; Animals, Newborn; Brain Ischemia; Disease Models, Animal; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitric Oxide Synthase Type III; Simvastatin; Stroke | 2005 |
13 trial(s) available for simvastatin and Brain Ischemia
Article | Year |
---|---|
Cost-Effectiveness of Simvastatin Plus Ezetimibe for Cardiovascular Prevention in Patients With a History of Acute Coronary Syndrome: Analysis of Results of the IMPROVE-IT Trial.
Topics: Acute Coronary Syndrome; Anticholesteremic Agents; Brain Ischemia; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ezetimibe; Female; Follow-Up Studies; Forecasting; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Quality-Adjusted Life Years; Saudi Arabia; Simvastatin; Treatment Outcome | 2018 |
Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial.
Topics: Aged; Atherosclerosis; Brain Ischemia; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Male; Metabolic Syndrome; Middle Aged; Niacin; Simvastatin; Stroke; Thrombosis; Triglycerides | 2013 |
Interaction of clopidogrel and statins in secondary prevention after cerebral ischaemia - a randomized, double-blind, double-dummy crossover study.
Topics: Aged; Brain Ischemia; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Secondary Prevention; Simvastatin; Substrate Specificity; Ticlopidine | 2014 |
Effect of High-Dose Simvastatin on Cerebral Blood Flow and Static Autoregulation in Subarachnoid Hemorrhage.
Topics: Aged; Brain Ischemia; Cerebrovascular Circulation; Female; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Positron-Emission Tomography; Simvastatin; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2016 |
Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin).
Topics: Aged; Aged, 80 and over; Brain Ischemia; Double-Blind Method; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Outcome Assessment, Health Care; Simvastatin; Stroke; Tissue Plasminogen Activator | 2016 |
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
Topics: Blood Coagulation; Brain Ischemia; Cerebral Angiography; Cerebrovascular Circulation; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Intracranial Aneurysm; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies; Simvastatin; Subarachnoid Hemorrhage; Time Factors; Treatment Outcome | 2009 |
Increased cortisol levels are associated with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Adult; Aged; Blood Glucose; Brain Ischemia; Combined Modality Therapy; Double-Blind Method; Embolization, Therapeutic; Endothelium, Vascular; Female; Glasgow Coma Scale; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hypertension; Male; Middle Aged; Neurologic Examination; Prognosis; Simvastatin; Subarachnoid Hemorrhage, Traumatic; Surgical Instruments; von Willebrand Factor | 2010 |
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
Topics: Aged; Atherosclerosis; Brain Ischemia; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kaplan-Meier Estimate; Male; Medication Adherence; Middle Aged; Muscular Diseases; Niacin; Proportional Hazards Models; Simvastatin; Treatment Failure; Triglycerides | 2011 |
High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Brain Ischemia; China; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; Simvastatin; Subarachnoid Hemorrhage; Treatment Outcome; Young Adult | 2013 |
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome | 2004 |
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Brain; Brain Ischemia; Creatine Kinase; Double-Blind Method; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Middle Aged; Models, Statistical; Pilot Projects; Simvastatin; Subarachnoid Hemorrhage; Time Factors; Treatment Outcome; Vascular Diseases; Vasospasm, Intracranial | 2005 |
[Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatin].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Contraction; Platelet Aggregation Inhibitors; Simvastatin; Sinoatrial Node; Treatment Outcome; Warfarin | 2007 |
Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Brain Ischemia; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infections; Inflammation Mediators; Male; Middle Aged; Pilot Projects; Simvastatin; Stroke; Treatment Outcome | 2008 |
32 other study(ies) available for simvastatin and Brain Ischemia
Article | Year |
---|---|
Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy.
Topics: Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Rosuvastatin Calcium; Simvastatin; Stroke | 2023 |
Combined Treatment with Hydrophilic and Lipophilic Statins Improves Neurological Outcomes Following Experimental Cardiac Arrest in Mice.
Topics: Animals; Behavior, Animal; Blood Gas Analysis; Brain Edema; Brain Ischemia; CA1 Region, Hippocampal; Cardiopulmonary Resuscitation; Cytokines; Heart Arrest; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Neuroprotective Agents; Pravastatin; Random Allocation; Simvastatin; Survival Rate | 2020 |
Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.
Topics: Amine Oxidase (Copper-Containing); Animals; Brain; Brain Ischemia; Cell Adhesion; Cell Adhesion Molecules; Cell Line; Disease Models, Animal; E-Selectin; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Rats; Rats, Wistar; Simvastatin; Stroke; Vascular Cell Adhesion Molecule-1 | 2018 |
CT perfusion hypervolemia: brain ischemia or stroke mimic?
Topics: Aged; Angiography, Digital Subtraction; Brain Ischemia; Cerebral Angiography; Cerebrovascular Circulation; Clopidogrel; Computed Tomography Angiography; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Magnetic Resonance Angiography; Platelet Aggregation Inhibitors; Simvastatin; Stroke; Water-Electrolyte Imbalance | 2019 |
Simvastatin in subarachnoid haemorrhage: beyond the short-term--authors' reply.
Topics: Brain Ischemia; Female; Humans; Male; Simvastatin; Subarachnoid Hemorrhage | 2014 |
Simvastatin in subarachnoid haemorrhage: beyond the short-term.
Topics: Brain Ischemia; Female; Humans; Male; Simvastatin; Subarachnoid Hemorrhage | 2014 |
Increasing neurogenesis with fluoxetine, simvastatin and ascorbic Acid leads to functional recovery in ischemic stroke.
Topics: Animals; Ascorbic Acid; Brain; Brain Ischemia; Drug Therapy, Combination; Female; Fluoxetine; Male; Neurogenesis; Rats; Rats, Long-Evans; Rats, Wistar; Recovery of Function; Simvastatin; Stroke | 2015 |
Statin treatment reduces the risk of poststroke seizures.
Topics: Aged; Aged, 80 and over; Atorvastatin; Brain Ischemia; Cohort Studies; Epilepsy; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rosuvastatin Calcium; Seizures; Simvastatin; Stroke; Time Factors; Treatment Outcome | 2015 |
Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidemic rats.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Brain Ischemia; Carotid Artery, Common; Cytokines; Diabetes Mellitus, Experimental; Glutamic Acid; Hippocampus; Male; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Pioglitazone; Rats; Rats, Wistar; Reperfusion Injury; Signal Transduction; Simvastatin; Thiazolidinediones | 2015 |
Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in rats.
Topics: Animals; Biological Availability; Blood-Brain Barrier; Brain; Brain Ischemia; Drug Delivery Systems; Infarction, Middle Cerebral Artery; Kidney; Liposomes; Liver; Lung; Male; Rats, Wistar; Simvastatin; Spleen; Stroke; Tissue Distribution | 2016 |
Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke.
Topics: Angiopoietin-1; Animals; Blood Vessels; Blood-Brain Barrier; Brain Ischemia; Cell Movement; Doublecortin Domain Proteins; Doublecortin Protein; Endothelial Cells; Gene Expression Regulation; Male; Membrane Proteins; Microtubule-Associated Proteins; Neovascularization, Physiologic; Neurons; Neuropeptides; Occludin; Rats; Rats, Wistar; Receptor, TIE-2; Simvastatin; Stroke | 2009 |
A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality.
Topics: Anticholesteremic Agents; Brain Ischemia; Case-Control Studies; Female; Humans; Magnesium; Male; Middle Aged; Retrospective Studies; Simvastatin; Subarachnoid Hemorrhage; Survival Rate; Treatment Outcome | 2008 |
Reduction of ischemic brain injury in rats with normothermic and hyperthermic conditions.
Topics: Animals; Brain Edema; Brain Ischemia; Cerebrovascular Circulation; Combined Modality Therapy; Disease Models, Animal; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperthermia, Induced; Male; Rats; Rats, Sprague-Dawley; Simvastatin | 2008 |
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
Topics: Brain Ischemia; Cohort Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Retrospective Studies; Simvastatin; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2008 |
Combination treatment of experimental stroke with Niaspan and Simvastatin, reduces axonal damage and improves functional outcome.
Topics: Amyloid beta-Protein Precursor; Animals; Axons; Brain; Brain Ischemia; Calcium-Binding Proteins; Delayed-Action Preparations; Disease Models, Animal; Drug Therapy, Combination; GPI-Linked Proteins; Infarction, Middle Cerebral Artery; Male; Microfilament Proteins; Microglia; Myelin Proteins; Neuroprotective Agents; Niacin; Nogo Receptor 1; Random Allocation; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Peptide; Simvastatin; Stroke; Treatment Outcome | 2010 |
Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hyperlipidemias; Lipids; Male; Medical Records; Middle Aged; Neuroprotective Agents; Pyrroles; Retrospective Studies; Severity of Illness Index; Simvastatin; Statistics as Topic; Stroke; Stroke Rehabilitation; Treatment Outcome | 2010 |
Comparison of the post-embolization effects of tissue-plasminogen activator and simvastatin on neurological outcome in a clinically relevant rat model of acute ischemic stroke.
Topics: Animals; Brain; Brain Ischemia; Disease Models, Animal; Fibrinolytic Agents; Hypolipidemic Agents; Rats; Simvastatin; Statistics, Nonparametric; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2010 |
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Electrophysiology; Guinea Pigs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Infusions, Intravenous; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 1; Oxidation-Reduction; Proto-Oncogene Proteins c-akt; Simvastatin; Solubility; Vascular Resistance | 2011 |
Upregulation of protein phosphatase 2A and NR3A-pleiotropic effect of simvastatin on ischemic stroke rats.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Gene Expression Regulation; Genetic Pleiotropy; Infarction, Middle Cerebral Artery; Male; Okadaic Acid; Phosphorylation; Protein Phosphatase 2; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Simvastatin; Stroke; Up-Regulation | 2012 |
Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage.
Topics: Animals; Brain Chemistry; Brain Damage, Chronic; Brain Injuries; Brain Ischemia; Brain Mapping; Cerebral Arteries; Cerebral Cortex; Cerebral Infarction; Disease Models, Animal; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Simvastatin; Up-Regulation | 2003 |
Statins after ischemic stroke and transient ischemic attack: an advisory statement from the Stroke Council, American Heart Association, and American Stroke Association.
Topics: Brain Ischemia; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2004 |
Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia.
Topics: Animals; Atorvastatin; Brain Ischemia; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracranial Embolism; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyrroles; Simvastatin; Stroke; Tissue Plasminogen Activator | 2005 |
Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke.
Topics: Animals; Brain; Brain Ischemia; Cerebrovascular Circulation; Intracranial Embolism; Male; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion; Simvastatin; Stroke; Treatment Outcome | 2005 |
HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.
Topics: Brain Ischemia; Cholesterol, LDL; Cohort Studies; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Prospective Studies; Simvastatin; Stroke; Treatment Outcome | 2005 |
Activation of NF-kB and ERK1/2 after permanent focal ischemia is abolished by simvastatin treatment.
Topics: Animals; Brain; Brain Ischemia; Chemokine CCL2; Disease Models, Animal; Down-Regulation; Encephalitis; Enzyme Activation; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Interleukin-1; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; NF-kappa B; Rats; Rats, Sprague-Dawley; Simvastatin; Up-Regulation | 2006 |
Statins and cerebral vasomotor reactivity: implications for a new therapy?
Topics: Adult; Animals; Arginine; Atorvastatin; Brain Ischemia; Cerebrovascular Circulation; Clinical Trials, Phase II as Topic; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Intracranial Aneurysm; Mice; Middle Cerebral Artery; Nitric Oxide; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk Factors; Simvastatin; Stroke; Subarachnoid Hemorrhage; Ultrasonography, Doppler, Transcranial; Vasodilation; Vasomotor System; Vasospasm, Intracranial | 2006 |
[Effects of xuezhikang and simvastatin on cerebral ischemia-reperfusion injury in rat].
Topics: Animals; Brain; Brain Ischemia; Drugs, Chinese Herbal; Infarction, Middle Cerebral Artery; Male; Malondialdehyde; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Simvastatin | 2006 |
Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice.
Topics: Animals; Brain; Brain Ischemia; Diabetes Mellitus, Experimental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Infarction, Middle Cerebral Artery; Mice; Motor Activity; Neurologic Examination; Simvastatin | 2007 |
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Brain Edema; Brain Injuries; Brain Ischemia; Cerebrovascular Circulation; Chemotaxis, Leukocyte; Cognition Disorders; Cytokines; Disease Models, Animal; Encephalitis; Endothelial Cells; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Pyrroles; Recovery of Function; RNA, Messenger; Simvastatin; Treatment Outcome | 2007 |
Discontinuation of statin therapy and clinical outcome after ischemic stroke.
Topics: Aged; Atorvastatin; Brain Ischemia; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Pyrroles; Simvastatin; Stroke; Substance Withdrawal Syndrome | 2007 |
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage.
Topics: Brain Ischemia; Cohort Studies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Retrospective Studies; Simvastatin; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2008 |
Switching statins: can we do harm?
Topics: Brain Ischemia; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Middle Aged; National Health Programs; New Zealand; Simvastatin; Therapeutic Equivalency | 1998 |